These FDA approved eye drops could be a life-changer that might replace spectacles for millions


Presbyopia is a condition that causes loss of the eye’s ability to focus on nearby objects.

This condition is a part of aging. 

Presbyopia may become noticeable in your mid-40s and gradually becomes worse until 60 to 65. 


Presbyopia is caused by the hardening of the lens of our eye.

As the lens of our eyes becomes harder, it becomes less flexible.

So it becomes hard to change shape for focusing nearby objects. 

Thus the image appears blurred or out of focus.


Currently, more than 128 million Americans are affected by presbyopia. And the numbers keep growing. 


Presbyopia can’t be reversed, but it can be corrected by reading glasses, surgery, or laser treatments. 

But surgeries and laser treatments have several risk factors. 

Now we can use reading glasses and that might be enough for those who’re comfortable with them.


But still reading glasses is turning into an irritation for some people because of portable issues, comfort issues, etc. 


Now comes Vuity’s eyedrops. 

These novel eyedrops can adjust and reduce the pupil size.

The pilocarpine in the eyedrops is an active and powerful ingredient that can stimulate the movement of the pupil. 

Reducing the pupil size expands the depth of field and increases the depth of focus. So these eyedrops utilize our eye’s natural ability to focus by reducing the pupil size.


That’s how it works. 

New FDA-approved eye drops could replace reading glasses for millions
New FDA-approved eye drops could replace reading glasses for millions: “It’s definitely a life changer”



“Reducing the pupil size expands the depth of field or the depth of focus, and that allows you to focus at different ranges naturally,” said Dr. George Waring, principal investigator of human trials. 


Phase three of the human trial was held involving 750 individuals with presbyopia between the ages of 40 and 55. 

The result was outstanding because those who used Vuity’s eyedrops were able to focus and read an extra three or four lines. 


Toni Wright, one of the 750 participants in the clinical trial told CBS News, “It’s definitely a life changer. I was in denial because to me that was a sign of growing older, you know, needing to wear glasses”

The drug works best for people 40 to 55 years old.


“I would not need my readers as much, especially on the computer, where I would always need to have them on,” she added. 


A single bottle of drug can be used for 30 days. 

Although this drug has one or two side effects like a tiny headache and eye redness, this was only affected on 5% of the participants in the trial. 


“This is something that we anticipate will be well tolerated long term, but this will be evaluated and studied in a formal capacity,” said Dr. George Waring.


Read Next: Gene editing in the microbiome opens the possibility to Fight against a wide range of Diseases.